$20.80 -0.46 (-2.16%)
7/2/2009 4:00 PM

Martek Biosciences Corp. (MATK)

CAPS Rating: 4 out of 5

Develops and commercializes products derived from microalgae, fungi and other microbes. Products are nutritional oils used as ingredients in infant formula and foods, and as ingredients in and encapsulated for use as dietary supplements.

Current Price $20.80 Mkt Cap $706.53M
Open $0.00 P/E Ratio 17.43
Prev. Close $21.26 Div. (Yield) N/A (N/A)
Daily Range $20.58 - $21.07 Volume 0
52-Wk Range $15.36 - $39.60 Avg. Daily Vol. 0

MATK News and Articles

All stories about MATK

Caps

How do you think MATK will perform vs the S&P 500?

Add Stock to Watchlist

All Members

352 Outperform
15 Underperform
 

All-Star Members

72 Outperform
2 Underperform
 

Wall Street

6 Outperform
0 Underperform
 

Top MATK Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

pwalls01 (30.54)
Submitted April 24, 2008

Develops and commercializes products derived from microalgae, fungi and other microbes. Products are nutritional oils used as ingredients in infant formula and foods, and as ingredients in and encapsulated for use as dietary supplements.

0 Comments | Reply | Report this Post

alexferrari (< 20)
Submitted October 11, 2006

DHA powder is too expensive to be acepted by food manufacturers. DHA oil is not stable enough to be used in most food applications. Martek's oil will perform only as a niche product in some vegetarian foods.

0 Comments | Reply | Report this Post
MATK VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about MATK.

Recs

0
Member Avatar bigbonesmagoo (97.84) Submitted: 4/8/2009 10:32:19 PM : Outperform Start Price: $18.19 MATK Score: +5.33

Although the fish source is better for you (you need EPA as much as DHA but this is another story all together)--this pond scum nonsense will find its way into most every food...Limited nutritional benefit but plenty of profit benefit. Investing is all about perception....

Just not enough fish to go around--their scum product will BOOM!

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar SwordAgain (94.35) Submitted: 12/2/2008 10:09:02 PM : Outperform Start Price: $27.32 MATK Score: -31.55

12/11/08, 4:45 PM Good defensive play in bio.

Report this Post 2 Comments | Reply | Permalink

Recs

0
Member Avatar alcorsjr (47.19) Submitted: 11/9/2008 12:37:37 PM : Outperform Start Price: $28.61 MATK Score: -21.68

My favorite low-cost biotech. Their supplements will soon be in everything from baby formula to senior nutrition drinks. Columbia, MD company makes money and is bargain-priced. Also ripe for a takeover by a big PhRMA or food company.

Report this Post 0 Comments | Reply | Permalink
View All 55 Pitches »

Leaderboard

Find the members with the highest scoring picks in MATK.

Score Leader

SixEightFool

SixEightFool (86.26) Score: +40.46

The Score Leader is the member with the highest score across all their picks in MATK.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
tim2pac 98.78 3/22/2007 Outperform 1Y $20.30 +2.46% -37.41% +39.88
sewserious 84.60 3/22/2007 Outperform NS $20.31 +2.41% -37.31% +39.73
DranoeLX 35.68 3/22/2007 Outperform 1Y $20.33 +2.31% -37.38% +39.70
pmcd1983 98.37 3/22/2007 Outperform 5Y $20.34 +2.26% -37.34% +39.60
jnrocky 43.81 5/8/2007 Outperform NS $21.00 -0.95% -40.32% +39.37
Pranab74 < 20 3/27/2007 Outperform 1Y $20.39 +2.01% -37.25% +39.26 1 Comment
baisleyde 68.26 3/27/2007 Outperform NS $20.37 +2.11% -37.09% +39.20
OverAnalyze 94.54 3/30/2007 Outperform 3W $20.30 +2.46% -36.62% +39.08
harrison5046 97.31 3/22/2007 Outperform 5Y $20.49 +1.51% -37.27% +38.78
obiwankenobe1250 90.44 3/23/2007 Outperform NS $20.59 +1.03% -37.48% +38.51 1 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackCantorFitz 56.35 3/25/2009 Outperform NS $17.25 +20.58% +10.44% +10.14
TrackNorthlandSe 83.92 3/19/2009 Outperform NS $17.88 +16.33% +10.92% +5.41
TrackScottBleier 94.06 12/28/2007 Outperform 3M $29.37 -29.18% -39.03% +9.85
TrackBroadpoint.AmTech 79.36 10/8/2007 Outperform NS $30.48 -31.76% -42.15% +10.39
TrackSoros 79.40 9/30/2007 Outperform NS $29.03 +5.30% -13.94% +19.25 3/31/2008 @ $30.57 1 Comment
TrackNeedham 75.83 9/7/2006 Outperform NS $21.91 -5.07% -30.93% +25.87
TrackJimCramer 64.82 3/10/2006 Outperform 3W $33.09 -37.14% -30.18% -6.96

Featured Broker Partners